WASHINGTON — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment.
FDA approves a second Alzheimer’s drug that can modestly slow disease
- Post author:Randy Banks
- Post published:July 9, 2024
- Post category:News